It spreads particularly easily in close quarters, including daycares, cruise ships, universities and nursing homes. Norovirus ...

Fact checked by Nick Blackmer There is currently no vaccine for norovirus because of its many strains and the elusive nature ...

The biotech’s efforts to bring its vaccines to the country mean navigating political pushback in the U.S. and the risk of ...

Political and economic uncertainty hangs over the industry, while major bets on metabolic and immune disease drug research are set to play out.

Moderna stock was on track to see a weekly gain of 10% as of Wednesday following the first reported bird flu death in the US.

With a state grand jury report released Wednesday, Florida Gov. Ron DeSantis doubled down on the message he delivered often ...

Five years on from the first news of COVID, recent reports of an obscure respiratory virus in China may understandably raise ...

In absolute dollar amount, the Cambridge drugmaker had the biggest drop in market cap among any public Massachusetts company ...

Moderna stock has been volatile this week as the first death in the U.S. connected to bird flu was reported. Here's what you ...

Moderna stock was on track to see a weekly gain of over 20% as of Wednesday following the first reported bird flu death in the US.

The Covid-19 positivity rate has also seen a rise to 7.1% this past week, versus the 5.5% figure for the past four weeks.

Moderna’s current price is less than $20 below the psychologically significant $50 price level. Traders often focus on these ...